We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Astronics
ATRO
$3.47B
| $934K | 0.01% |
27,869
+5,584
| +25% | +$176K |
|
952
Village Super Market
VLGEA
$636M
| $933K | 0.01% |
35,209
+32,041
| +1,011% | +$869K |
|
953
Matthews International
MATW
$878M
| $928K | 0.01% |
26,636
+21,259
| +395% | +$778K |
|
954
Ituran Location and Control
ITRN
$1.09B
| $927K | 0.01% |
+30,816
| New | +$1.04M |
|
|
WTRE
955
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $918K | 0.01% |
+33,493
| New | +$886K |
|
956
Vera Bradley
VRA
$106M
| $911K | 0.01% |
75,954
-66,910
| -47% | -$792K |
|
957
Target Hospitality
TH
$1.6B
| $908K | 0.01% |
+99,732
| New | +$1.01M |
|
958
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.32B
| $907K | 0.01% |
+24,800
| New | +$934K |
|
959
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.47B
| $904K | 0.01% |
10,225
-22,275
| -69% | -$2.57M |
|
960
T-Mobile US
TMUS
$190B
| $890K | 0.01% |
+12,002
| New | +$891K |
|
961
Lantheus
LNTH
$7.03B
| $884K | 0.01% |
+31,247
| New | +$793K |
|
|
EXPR
962
DELISTED
Express, Inc.
EXPR
| $884K | 0.01% |
16,182
-14,935
| -48% | -$1.02M |
|
963
Heritage Insurance Holdings
HRTG
$864M
| $881K | 0.01% |
57,162
+30,494
| +114% | +$449K |
|
964
Northwest Natural Holdings
NWN
$2.16B
| $881K | 0.01% |
+12,679
| New | +$858K |
|
|
HAYN
965
DELISTED
Haynes International, Inc.
HAYN
| $877K | 0.01% |
+27,583
| New | +$888K |
|
966
RE/MAX Holdings
RMAX
$207M
| $873K | 0.01% |
+28,366
| New | +$1.02M |
|
967
Flowserve
FLS
$9.29B
| $870K | 0.01% |
+16,514
| New | +$811K |
|
968
CRH
CRH
$68.7B
| $868K | 0.01% |
+26,510
| New | +$862K |
|
969
Crinetics Pharmaceuticals
CRNX
$8.87B
| $857K | 0.01% |
34,238
+176
| +0.5% | +$4.36K |
|
970
Martin Midstream Partners
MMLP
$98.6M
| $857K | 0.01% |
+120,009
| New | +$989K |
|
971
Ironwood Pharmaceuticals
IRWD
$644M
| $856K | 0.01% |
78,269
-69,489
| -47% | -$778K |
|
972
Trip.com Group
TCOM
$28.2B
| $856K | 0.01% |
+23,199
| New | +$915K |
|
973
Anika Therapeutics
ANIK
$200M
| $855K | 0.01% |
21,040
-34,970
| -62% | -$1.28M |
|
974
Arcos Dorados Holdings
ARCO
$1.75B
| $854K | 0.01% |
120,522
-273,132
| -69% | -$1.8M |
|
975
Northern Trust
NTRS
$22.4B
| $845K | 0.01% |
9,389
-62,538
| -87% | -$5.76M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.